CITIGROUP INC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 225 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,703,019
-59.8%
1,922,143
-28.7%
0.00%
-66.7%
Q3 2022$4,232,000
+18.2%
2,695,925
+51.4%
0.00%0.0%
Q2 2022$3,579,000
+249.9%
1,780,555
+305.5%
0.00%
+200.0%
Q1 2022$1,023,000
-71.3%
439,090
-42.7%
0.00%
-50.0%
Q4 2021$3,562,000
+33.0%
766,089
+118.3%
0.00%0.0%
Q3 2021$2,678,000
-51.5%
350,959
-38.4%
0.00%
-33.3%
Q2 2021$5,517,000
+38.1%
569,380
+17.9%
0.00%0.0%
Q1 2021$3,995,000
+330.0%
483,066
+255.3%
0.00%
Q4 2020$929,000
-6.2%
135,951
+53.0%
0.00%
Q3 2020$990,000
-14.4%
88,842
-51.8%
0.00%
-100.0%
Q2 2020$1,156,000
+1170.3%
184,134
+273.7%
0.00%
Q1 2020$91,000
-7.1%
49,275
+69.5%
0.00%
Q4 2019$98,000
+206.2%
29,078
+96.3%
0.00%
Q3 2019$32,000
-67.3%
14,814
-59.6%
0.00%
Q2 2019$98,000
-41.7%
36,672
+3.4%
0.00%
Q1 2019$168,000
-92.0%
35,470
-96.0%
0.00%
-100.0%
Q4 2018$2,113,000
+47.5%
880,598
+170.3%
0.00%
+100.0%
Q3 2018$1,433,000
-8.3%
325,729
+50.0%
0.00%0.0%
Q2 2018$1,563,000
+46.1%
217,100
+4.5%
0.00%0.0%
Q1 2018$1,070,000
+1918.9%
207,758
+1384.0%
0.00%
Q4 2017$53,000
+657.1%
14,000
+250.0%
0.00%
Q3 2017$7,000
-30.0%
4,000
-20.0%
0.00%
Q2 2017$10,000
-58.3%
5,000
-17.8%
0.00%
Q1 2017$24,000
-17.2%
6,084
+4.0%
0.00%
Q4 2016$29,000
-35.6%
5,8500.0%0.00%
Q3 2016$45,000
+32.4%
5,850
-2.5%
0.00%
Q2 2016$34,000
-69.6%
6,000
-71.3%
0.00%
Q1 2016$112,000
-13.2%
20,883
+40.9%
0.00%
Q4 2015$129,000
+134.5%
14,818
+125.4%
0.00%
Q3 2015$55,000
+14.6%
6,573
+139.3%
0.00%
Q2 2015$48,000
+77.8%
2,747
+15.5%
0.00%
Q1 2015$27,0002,378
+5430.2%
0.00%
Q4 2014$0
-100.0%
43
-98.5%
0.00%
Q3 2014$13,0002,900
+16011.1%
0.00%
Q2 2014$0180.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,623,533$22,851,0006.45%
Avoro Capital Advisors LLC 1,146,579$9,987,0003.44%
Cormorant Asset Management, LP 2,095,334$18,250,0002.18%
Healthcare Value Capital, LLC 50,000$436,0000.72%
CAPITAL MANAGEMENT ASSOCIATES /NY/ 20,000$174,0000.25%
SABBY MANAGEMENT, LLC 300,000$2,613,0000.14%
STRATEGIC INVESTMENT MANAGEMENT, LLC 20,398$177,0000.10%
Granite Investment Partners, LLC 89,622$781,0000.07%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 54,634$476,0000.06%
Trexquant Investment LP 67,929$592,0000.05%
View complete list of SORRENTO THERAPEUTICS INC shareholders